• 1
    Bugianesi E, Leone N, Vanni E, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002; 123: 13440.
  • 2
    Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003; 37: 120219.
  • 3
    Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 170525.
  • 4
    Pagano G, Pacini G, Musso G, et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 2002; 35: 36772.
  • 5
    Ge L. Body mass index in young Chinese adults. Asia Pac J Clin Nutr 1997; 6: 1759.
  • 6
    Cockram CS, Woo J, Lau E, et al. The prevalence of diabetes mellitus and impaired glucose tolerance among Hong Kong Chinese adults of working age. Diabetes Res Clin Pract 1993; 21: 6773.
  • 7
    Chan M. Department of Health Annual Report 1999–2000. The Government of the Hong Kong SAR, 2001.
  • 8
    Ko GT, Wu MM, Wai HP, et al. Rapid increase in the prevalence of undiagnosed diabetes and impaired fasting glucose in asymptomatic Hong Kong Chinese. Diabetes Care 1999; 22: 17512.
  • 9
    Cockram CS, Chan JCN. The epidemiology of diabetes in the Western Pacific region (excluding Japan). In: Turtle, JR, ed. Diabetes in the New Millennium. Sydney: Pot Still Press, 1999: 1122.
  • 10
    Wong VW, Chan HL, Hui AY, et al. Clinical and histological features of non-alcoholic fatty liver disease in Hong Kong Chinese. Aliment Pharmacol Ther 2004; 20: 459.
  • 11
    Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 122131.
  • 12
    Powell EE, Cooksley WG, Hanson R, et al. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990; 11: 7480.
  • 13
    Teli MR, Day CP, Burt AD, et al. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 1995; 346: 98790.
  • 14
    Teli MR, James OF, Burt AD, et al. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995; 22: 17149.
  • 15
    Chitturi S, Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 2001; 21: 2741.
  • 16
    Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 246774.
    Direct Link:
  • 17
    World Health Organization. The Asia-Pacific Perspective: Redefining Obesity and its Treatment. Geneva: World Health Organization, 2000.
  • 18
    Fassio E, Alvarez E, Dominguez N, et al. Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies. Hepatology 2004; 40: 8206.
  • 19
    Ko GT, Tang J, Chan JC, et al. Lower BMI cut-off value to define obesity in Hong Kong Chinese: an analysis based on body fat assessment by bioelectrical impedance. Br J Nutr 2001; 85: 23942.
  • 20
    Eriksson S, Eriksson KF, Bondesson L. Nonalcoholic steatohepatitis in obesity: a reversible condition. Acta Med Scand 1986; 220: 838.
  • 21
    Chitturi S, Abeygunasekera S, Farrell GC, et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002; 35: 3739.
  • 22
    Woo J, Ho SC, Sham A, et al. Diet and glucose tolerance in a Chinese population. Eur J Clin Nutr 2003; 57: 52330.
  • 23
    Chitturi S, Farrell GC, George J. Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock? J Gastroenterol Hepatol 2004; 19: 36874.